Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

moattractant for CD8 + T lymphocytes
and an inhibitor of IL-8-induced CD4 +
T lymphocyte migration. J. Immunol.
151: 4545.
149 Rowbottom, A. W., M. A. Lepper,
R. J. Garland, C. V. Cox and E. G. Corley.
1999. Interleukin-10-induced CD8
cell proliferation. Immunology 98: 80.
150 Chen,W. F. and A. Zlotnik. 1991. IL-
10: a novel cytotoxic T cell differentiation
factor. J. Immunol. 147: 528.
151 MacNeil, I. A., T. Suda, K. W. Moore,
T. R. Mosmann and A. Zlotnik. 1990.
IL-10, a novel growth cofactor for mature
and immature T cells. J. Immunol.
145: 4167.
152 Santin, A. D., P. L. Hermonat, A. Ravaggi,
S. Bellone, S. Pecorelli,
J. J. Roman, G. P. Parham and
M. J. Cannon. 2000. Interleukin-10 increases
T h1 cytokine production and cytotoxic
potential in human papillomavirus-specific
CD8(+) cytotoxic T lymphocytes.
J. Virol. 74: 4729.
153 Yang, G., K. E. Hellstrom, M. T. Mizuno
and L. Chen. 1995. In vitro priming
of tumor-reactive cytolytic T lymphocytes
by combining IL-10 with B7-
CD28 costimulation. J. Immunol. 155:
3897.
154 Groux, H., F. Cottrez, M. Rouleau,
S. Mauze, S. Antonenko, S. Hurst,
T. McNeil, M. Bigler, M. G. Roncarolo
and R. L. Coffman. 1999. A transgenic
model to analyze the immunoregulatory
role of IL-10 secreted by antigen-presenting
cells. J. Immunol. 162:
1723.
155 Carson,W. E., M. J. Lindemann,
R. Baiocchi, M. Linett, J. C. Tan,
C. C. Chou, S. Narula and M. A. Caligiuri.
1995. The functional characterization
of interleukin-10 receptor expression
on human natural killer cells.
Blood 85: 3577.
156 Kundu, N., T. L. Beaty, M. J. Jackson
and A. M. Fulton. 1996. Antimetastatic
and antitumor activities of interleukin
10 in a murine model of breast cancer.
J. Natl Cancer Inst. 88: 536.
157 Kundu, N. and A. M. Fulton. 1997. Interleukin-10
inhibits tumor metastasis,
downregulates MHC class I and enhances
NK lysis. Cell Immunol. 180: 55.
References
158 Qin, Z., G. Noffz, M. Mohaupt and
T. Blankenstein. 1997. Interleukin-10
prevents dendritic cell accumulation
and vaccination with granulocytemacrophage
colony-stimulating factor
gene-modified tumor cells. J. Immunol.
159: 770.
159 Allavena, P., L. Piemonti, D. Longoni,
S. Bernasconi, A. Stoppacciaro,
L. Ruco and A. Mantovani. 1998. IL-
10 prevents the differentiation of monocytes
to dendritic cells but promotes
their maturation to macrophages. Eur.
J. Immunol. 28: 359.
160 Allavena, P., L. Piemonti, D. Longoni,
S. Bernasconi, A. Stoppacciaro,
L. Ruco and A. Mantovani.
1997. IL-10 prevents the generation of
dendritic cells from CD14 + blood
monocytes, promotes the differentiation
to mature macrophages and stimulates
endocytosis of FITC±dextran. Adv.
Exp. Med. Biol 417: 323.
161 Fortsch, D., M. Rollinghoff and
S. Stenger. 2000. IL-10 converts human
dendritic cells into macrophagelike
cells with increased antibacterial activity
against virulent Mycobacterium tuberculosis.
J. Immunol. 165: 978.
162 Takayama, T., H. Tahara and
A. W. Thomson. 2001. Differential effects
of myeloid dendritic cells retrovirally
transduced to express mammalian
or viral interleukin-10 on cytotoxic T
lymphocyte and natural killer cell functions
and resistance to tumor growth.
Transplantation 71: 1334.
163 Corinti, S., C. Albanesi, A. la Sala,
S. Pastore and G. Girolomoni. 2001.
Regulatory activity of autocrine IL-10
on dendritic cell functions. J. Immunol.
166: 4312.
164 Ludewig, B., D. Graf, H. R. Gelderblom,Y.
Becker, R. A. Kroczek and
G. Pauli. 1995. Spontaneous apoptosis
of dendritic cells is efficiently inhibited
by TRAP (CD40 ligand) and TNF-a, but
strongly enhanced by interleukin-10.
Eur. J. Immunol. 25: 1943.
165 Alleva, D. G., C. J. Burger and
K. D. Elgert. 1994. Increased sensitivity
of tumor-bearing host macrophages
to interleukin-10: a counter-balancing
145